The EORTC Melanoma Cooperative Group adjuvant trial programmeon maligmant melanoma: prognosis versus efficacy, toxicity and costs

Lex Eggermont

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)127-131
Number of pages5
JournalMelanoma Research
Volume7
Issue numbers2
Publication statusPublished - 1997

Cite this